Cancer Research

The daunting reality of high-risk localized prostate cancer is that surgical intervention often feels like an incomplete solution, especially when half of patients face a biological recurrence within just five years of their primary treatment. This aggressive form of the disease, which accounts for

The moment a physician can decode the specific genetic vulnerabilities of a tumor marks the beginning of a profound shift in how the medical community approaches the most aggressive forms of human disease. At the 2026 American Society for Clinical Oncology Annual Meeting, the focus transitioned

The recent surge in transformative biotechnologies has brought the medical community to a pivotal moment where curing previously terminal conditions is no longer a distant aspiration but a practical reality for many patients. However, the path from a successful laboratory breakthrough to a

Indigenous women across North America occupy a perplexing position in the landscape of oncological data, where they historically demonstrate lower overall rates of breast cancer compared to their white counterparts but suffer from a far higher death rate. This disparity has persisted despite

The election of Simon R. Cherry to the Royal Society marks a monumental milestone in the field of medical physics, distinguishing him as one of the few global leaders whose contributions have fundamentally altered the landscape of diagnostic imaging and clinical research. As a Distinguished

The precision of genetic engineering has long been hampered by the biological trauma that occurs when molecular scissors sever both strands of the double helix simultaneously, often leading to unintended cellular consequences. Scientists at Cornell University have recently addressed this